Evaluation of dysmenorrhea

Evidence last reviewed: 21 Jul 2026
Topic last updated: 06 Aug 2026

Summary

Differentials

Common

  • Primary dysmenorrhea
  • Pelvic inflammatory disease
  • Endometriosis
  • Adenomyosis
  • Uterine leiomyoma (fibroids)
  • Uterine polyps
Full details

Uncommon

  • Ovarian cyst with hemorrhage
  • Ovarian torsion
  • Obstructive Mullerian duct anomalies
  • Cervical stenosis
  • Intrauterine devices
  • Asherman syndrome
  • Pelvic congestion syndrome
Full details

Contributors

Authors

Alaina R. Francis, BSC, MHSc, MD

FRANZCOG trainee and Gynaecology Fellow

Royal Women’s Hospital

Parkville

Victoria

Australia

Disclosures

AF declares that she has no competing interests.

Martha Hickey, BA Hon, MSc (Clinical Psychology), MBChB, FRCOG, FRANZCOG, MD

Professor

Department of Obstetrics, Gynaecology and Newborn Health

University of Melbourne

Parkville

Victoria

Australia

Head of Menopause Services

The Women’s Hospital

Victoria

Australia

Disclosures

MH declares that she has no competing interests.

Andrew Wemyss Horne, MB ChB, PhD, FRCOG, FRCP Edin

Professor of Gynaecology and Reproductive Sciences, Honorary Consultant Gynaecologist

MRC Centre for Reproductive Health

University of Edinburgh

Edinburgh

UK

Disclosures

AWH is listed as coinventor on a patent application (UK Patent App No. 2217921.2, International Patent App No. PCT/GB2023/053076) relating to a predictive test to determine the efficacy of gabapentin for chronic pelvic pain treatment. His institution has received honoraria for consultancy from Roche Diagnostics, Gesynta, and Joii and grant funding from Roche Diagnostics. AWH has received lecture fees from Theramex and Gedeon Richter and grant funding from the EU (Horizon), NIHR, CSO, UKRI, and Wellbeing of Women.

Michelle Cooper, MBChB, MRCOG, MFSRH, DipGUM

Consultant in Gynaecology and Sexual Health

Chalmers Centre

NHS Lothian

Edinburgh

UK

Disclosures

MC declares that she has received research grant funding from the Chief Scientist Office (Scottish Government) and serves as a member of the BMJ SRH Editorial board.

Acknowledgements

Dr Alaina Francis, Professor Martha Hickey, Professor Andrew Wemyss Horne, and Dr Michelle Cooper would like to gratefully acknowledge Dr Mary Ann Lumsden, Dr Stamatina Iliodromiti, Dr Suketu M. Mansuria, and Dr Linda C. Lang, the previous contributors to this topic.

Disclosures

MAL, SI, SMM, and LCL declare that they have no competing interests.

Peer reviewers

Bradley Bruggeman, MD

Assistant Professor

Division of Academic Specialists in General Obstetrics and Gynecology

University of Florida College of Medicine

Gainesville, FL

Disclosures

BB declares that he has no competing interests.

Peter Reid, BSc, MD, FRCOG, FRANZCOG

Specialist Gynaecologist

Peel Health Campus

Mandurah

Australia

Disclosures

PR declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Burnett M. Guideline no. 345: primary dysmenorrhea. J Obstet Gynaecol Can. 2025 May;47(5):102840. Abstract

Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020 Jan 21;323(3):268-9. Abstract

Singh SS, Allaire C, Al-Nourhji O, et al. Guideline no. 449: diagnosis and impact of endometriosis - a Canadian guideline. J Obstet Gynaecol Can. 2024 May;46(5):102450. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer